Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Vionnet

Showing results (1-10 of 9) with videos related to

Pageof 1
Sort By:
Revue Medicale Suisse|May 20, 2014
[Shingles vaccine: which recommendations in 2014?]J Vionnet, K Hart, F Spertini
Glycobiology|August 2, 2001
Elongation of alternating alpha 2,8/2,9 polysialic acid by the Escherichia coli K92 polysialyltransferaseM M McGowen, J Vionnet, W F Vann
International Journal of Oncology|May 17, 2011
Platinum-DNA adduct in head and neck-cancer patients receiving Cisplatin and Carboplatin chemotherapyR Parker, I Dimery, M Dabholkar, et al.
Oncology Reports|May 21, 2011
Expression of an alternatively spliced ercc1 messenger-RNA species, is related to reduced DNA-repair efficiency in human T-lymphocytesM Dabholkar, J Vionnet, R Parker, et al.
The Journal of Clinical Investigation|August 1, 1994
Messenger RNA levels of XPAC and ERCC1 in ovarian cancer tissue correlate with response to platinum-based chemotherapyM Dabholkar, J Vionnet, F Bostick-Bruton, et al.
Glycobiology|April 20, 1999
Purification of CMP-N-acetylneuraminic acid synthetase from bovine anterior pituitary glandsJ Vionnet, N Concepcion, T Warner, et al.
Biochemical Pharmacology|November 15, 2000
Increased mRNA levels of xeroderma pigmentosum complementation group B (XPB) and Cockayne's syndrome complementation group B (CSB) without increased mRNA levels of multidrug-resistance gene (MDR1) or metallothionein-II (MT-II) in platinum-resistant human ovarian cancer tissuesM Dabholkar, K Thornton, J Vionnet, et al.
Basic Life Sciences|January 1, 1990
Peripheral blood leukocytes as a surrogate marker for cisplatin drug resistance: studies of adduct levels and the repair gene ERCC1R J Parker, M C Poirier, F Bostick-Bruton, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|April 26, 2016
HIV-Positive-to-HIV-Positive Liver TransplantationA Calmy, C van Delden, E Giostra, et al.
Pageof 1

Showing results (1-10 of 9) with videos related to

Sort By:
Pageof 1
Revue Medicale Suisse|May 20, 2014
[Shingles vaccine: which recommendations in 2014?]J Vionnet, K Hart, F Spertini
Glycobiology|August 2, 2001
Elongation of alternating alpha 2,8/2,9 polysialic acid by the Escherichia coli K92 polysialyltransferaseM M McGowen, J Vionnet, W F Vann
International Journal of Oncology|May 17, 2011
Platinum-DNA adduct in head and neck-cancer patients receiving Cisplatin and Carboplatin chemotherapyR Parker, I Dimery, M Dabholkar, et al.
Oncology Reports|May 21, 2011
Expression of an alternatively spliced ercc1 messenger-RNA species, is related to reduced DNA-repair efficiency in human T-lymphocytesM Dabholkar, J Vionnet, R Parker, et al.
The Journal of Clinical Investigation|August 1, 1994
Messenger RNA levels of XPAC and ERCC1 in ovarian cancer tissue correlate with response to platinum-based chemotherapyM Dabholkar, J Vionnet, F Bostick-Bruton, et al.
Glycobiology|April 20, 1999
Purification of CMP-N-acetylneuraminic acid synthetase from bovine anterior pituitary glandsJ Vionnet, N Concepcion, T Warner, et al.
Biochemical Pharmacology|November 15, 2000
Increased mRNA levels of xeroderma pigmentosum complementation group B (XPB) and Cockayne's syndrome complementation group B (CSB) without increased mRNA levels of multidrug-resistance gene (MDR1) or metallothionein-II (MT-II) in platinum-resistant human ovarian cancer tissuesM Dabholkar, K Thornton, J Vionnet, et al.
Basic Life Sciences|January 1, 1990
Peripheral blood leukocytes as a surrogate marker for cisplatin drug resistance: studies of adduct levels and the repair gene ERCC1R J Parker, M C Poirier, F Bostick-Bruton, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|April 26, 2016
HIV-Positive-to-HIV-Positive Liver TransplantationA Calmy, C van Delden, E Giostra, et al.
Pageof 1